homeearnings News

Dr Reddy’s numbers on expected lines, outlook on company remains positive: Analysts

earnings | Oct 28, 2020 5:45 PM IST

Dr Reddy’s numbers on expected lines, outlook on company remains positive: Analysts

Mini

“DRL numbers are on the expected line,” said Cyndrella Carvalho of Centrum Broking in an interview with CNBC-TV18. The outlook on the company remains positive, she added.

Dr Reddy’s Laboratories (DRL) today reported a good set of numbers for Q2FY21.

Recommended Articles

View All

“DRL numbers are on the expected line,” said Cyndrella Carvalho of Centrum Broking in an interview with CNBC-TV18. The outlook on the company remains positive, she added.
Vishal Manchanda, Pharma Analyst of Nirmal Bang Institutional Equities, said, “Numbers continue to outperform. Even this quarter was a beat on the consensus numbers largely driven by India doing extremely well.”
“We remain in momentum and this momentum should continue to build with every quarter as they launch some big products in the US, very good set of numbers,” Manchanda added.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng